American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 527-535 , October 2004

Quality of life in keratoconus

  • Steven M. Kymes, PhD

      Affiliations

    • Washington University School of Medicine, St. Louis, Missouri, USA (S.M.K., M.O.G.)
  • ,
  • Jeffrey J. Walline, OD, PhD

      Affiliations

    • Ohio State University College of Optometry, Columbus, Ohio, USA (J.J.W., K.Z.)
  • ,
  • Karla Zadnik, OD, PhD

      Affiliations

    • Ohio State University College of Optometry, Columbus, Ohio, USA (J.J.W., K.Z.)
    • Corresponding Author InformationInquiries to Steven M. Kymes, PhD, Washington University Medical School, Department of Ophthalmology & Visual Sciences, Campus Box 8096, 660 S. Euclid Avenue, St. Louis, Missouri 63110–1093, USA; fax: (314) 362-0231
  • ,
  • Mae O. Gordon, PhD

      Affiliations

    • Washington University School of Medicine, St. Louis, Missouri, USA (S.M.K., M.O.G.)
  • ,
  • Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group

      Affiliations

    • Washington University School of Medicine, St. Louis, Missouri, USA (S.M.K., M.O.G.)

,Accepted 13 April 2004.

References 

  1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322
  2. CLEK Study Group Zadnik K, Gordon MO, Barr JT, Edrington TB. Biomicroscopic signs and disease severity in keratoconus. Cornea. 1996;15:139–146
  3. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101:267–273
  4. Zadnik K, Barr JT, Edrington TB, et al.  Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci. 1998;39:2537–2546
  5. Mangione CM, Lee PP, Gutierrez PR, et al.  Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–1058
  6. Mangione CM, Phillips RS, Seddon JM, et al.  Development of the “Activities of Daily Vision Scale”. A measure of visual functional status. Med Care. 1992;30:1111–1126
  7. Sloane ME, Ball K, Owsley C. The visual activities questionnaire. Developing an instrument for assessing problems in everyday visual tasks. Washington, DC: Optical Society of America; 1999;
  8. Steinberg EP, Tilesch JM, Schein OD, et al.  The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112:630–638
  9. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53:740–745
  10. Walline JJ, Bailey MD, Zadnik K. Vision-specific quality of life and modes of refractive error correction. Optom Vis Sci. 2000;77:648–652
  11. deVellis RF. Scale development: theory and applications. Newbury Park: Sage; 1991;
  12. Age-Related Eye Disease Study Group Clemons TE, Chew EY, Bressler SB, McBee W. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10. Arch Ophthalmol. 2003;121:211–217
  13. Mangione CM, Berry S, Spritzer K, et al.  Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire (results from focus groups with visually impaired persons). Arch Ophthalmol. 1998;116:227–233
  14. Clancy CM, Eisenberg JM. Outcomes research (measuring the end results of care). Science. 1998;282:245–246
  15. Bergner M. Quality of life, health status, and clinical research. Med Care. 1989;27:S148–S156
  16. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. JAMA. 1993;118:622–629
  17. Cella DF, Bonomi AE. Measuring quality of life (1995 update). Oncology. 1995;9(Suppl):47–60
  18. Bamfi F, Olivieri A, Arpinelli F, et al.  Measuring quality of life in dyspeptic patients (development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4,000 patients). Am J Gastroenterol. 1999;94:730–738
  19. Hawthorne G, Richardson J, Atherton N. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med. 2001;33:358–370
  20. McHorney CA. Generic health measurement (past accomplishments and a measurement paradigm for the 21st century). Ann Intern Med. 1997;127:743–750
  21. Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119:841–849
  22. Klein R, Moss SE, Klein BEK, et al.  The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus (the Wisconsin Epidemiologic Study of Diabetic Retinopathy). Arch Ophthalmol. 2001;119:733–740
  23. Jampel HD, Schwartz A, Pollack I, et al.  Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma. 2002;11:154–163
  24. Berg-Weger M, Rubio DM, Tebb SS. Depression as a mediator (viewing caregiver well-being and strain in a different light). Fam Soc. 2000;81:162–173
  25. Swartz NG, Cohen EJ, Scott DG, Genvert GI, Arentsen JJ, Laibson PR. Personality and keratoconus. CLAO J. 1990;16:62–64
  26. Lass JH, Lembach RG, Park SB, et al.  Clinical management of keratoconus. A multicenter analysis. Ophthalmology. 1990;97:433–445
  27. Smiddy WE, Hamburg TR, Kracher GP, Stark WJ. Keratoconus. Contact lens or keratoplasty?. Ophthalmology. 1988;95:487–492

 A listing of the additional investigators who participated in the study appears in the Appendix.The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study is supported by the National Eye Institute/National Institutes of Health, grants EY10419, EY10069, EY10077, EY12656, and EY02687. It also was supported by Conforma Contact Lenses, Paragon Vision Sciences, CIBA Vision Corporation, and the Ohio Lions Eye Research Foundation.

PII: S0002-9394(04)00412-X

doi: 10.1016/j.ajo.2004.04.031

American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 527-535 , October 2004